Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis

A meta-analysis to better evaluate the existing evidence about the activity and safety of ICB in the setting of unresectable or metastatic advanced TET previously treated with platinum-based chemotherapy.

Radiotherapy for Thymic Epithelial Tumors: What Is The Optimal Dose? A Systematic Review

This overview can spark new evidence to define the optimal RT dose for each TETs category.